Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer

Clinical trial NCT00002939 · COMPLETED

Trial details

NCT number: NCT00002939
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1996-11-01
Primary completion: 2001-02-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.